GLMD
Price
$0.33
Change
-$0.01 (-2.94%)
Updated
Mar 28, 6:59 PM EST
40 days until earnings call
SPRO
Price
$1.72
Change
-$0.03 (-1.71%)
Updated
Mar 28, 6:59 PM EST
41 days until earnings call
Ad is loading...

Compare trend and price GLMD vs SPRO

Header iconGLMD vs SPRO Comparison
Open Charts GLMD vs SPROBanner chart's image
Galmed Pharmaceuticals
Price$0.33
Change-$0.01 (-2.94%)
Volume$26.04K
CapitalizationN/A
Spero Therapeutics
Price$1.72
Change-$0.03 (-1.71%)
Volume$103.59K
CapitalizationN/A
View a ticker or compare two or three
GLMD vs SPRO Comparison Chart

Loading...

GLMDDaily Signal changed days agoGain/Loss if shorted
 
Show more...
SPRODaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
GLMD vs. SPRO commentary
Mar 29, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLMD is a StrongBuy and SPRO is a Hold.

COMPARISON
Comparison
Mar 29, 2024
Stock price -- (GLMD: $0.35 vs. SPRO: $1.72)
Brand notoriety: GLMD and SPRO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GLMD: 24% vs. SPRO: 44%
Market capitalization -- GLMD: $1.39M vs. SPRO: $92.65M
GLMD [@Biotechnology] is valued at $1.39M. SPRO’s [@Biotechnology] market capitalization is $92.65M. The market cap for tickers in the [@Biotechnology] industry ranges from $570.99B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLMD’s FA Score shows that 0 FA rating(s) are green whileSPRO’s FA Score has 1 green FA rating(s).

  • GLMD’s FA Score: 0 green, 5 red.
  • SPRO’s FA Score: 1 green, 4 red.
According to our system of comparison, SPRO is a better buy in the long-term than GLMD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLMD’s TA Score shows that 5 TA indicator(s) are bullish while SPRO’s TA Score has 2 bullish TA indicator(s).

  • GLMD’s TA Score: 5 bullish, 4 bearish.
  • SPRO’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, GLMD is a better buy in the short-term than SPRO.

Price Growth

GLMD (@Biotechnology) experienced а +9.52% price change this week, while SPRO (@Biotechnology) price change was -0.58% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.98%. For the same industry, the average monthly price growth was +8.91%, and the average quarterly price growth was +90.55%.

Reported Earning Dates

GLMD is expected to report earnings on May 08, 2024.

SPRO is expected to report earnings on May 09, 2024.

Industries' Descriptions

@Biotechnology (+4.98% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for GLMD with price predictions.
OPEN
A.I.dvisor published
a Summary for SPRO with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
SPRO($92.7M) has a higher market cap than GLMD($1.39M). SPRO YTD gains are higher at: 17.007 vs. GLMD (-23.890). SPRO has higher annual earnings (EBITDA): 25.8M vs. GLMD (-11.67M). SPRO has more cash in the bank: 76.3M vs. GLMD (9.33M). GLMD has less debt than SPRO: GLMD (0) vs SPRO (5.54M). SPRO has higher revenues than GLMD: SPRO (96.7M) vs GLMD (0).
GLMDSPROGLMD / SPRO
Capitalization1.39M92.7M1%
EBITDA-11.67M25.8M-45%
Gain YTD-23.89017.007-140%
P/E RatioN/A4.00-
Revenue096.7M-
Total Cash9.33M76.3M12%
Total Debt05.54M-
FUNDAMENTALS RATINGS
GLMD vs SPRO: Fundamental Ratings
GLMD
SPRO
OUTLOOK RATING
1..100
184
VALUATION
overvalued / fair valued / undervalued
1..100
41
Fair valued
28
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9840
PRICE GROWTH RATING
1..100
8943
P/E GROWTH RATING
1..100
10093
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SPRO's Valuation (28) in the Pharmaceuticals Major industry is in the same range as GLMD (41) in the Pharmaceuticals Other industry. This means that SPRO’s stock grew similarly to GLMD’s over the last 12 months.

SPRO's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as GLMD (100) in the Pharmaceuticals Other industry. This means that SPRO’s stock grew similarly to GLMD’s over the last 12 months.

SPRO's SMR Rating (40) in the Pharmaceuticals Major industry is somewhat better than the same rating for GLMD (98) in the Pharmaceuticals Other industry. This means that SPRO’s stock grew somewhat faster than GLMD’s over the last 12 months.

SPRO's Price Growth Rating (43) in the Pharmaceuticals Major industry is somewhat better than the same rating for GLMD (89) in the Pharmaceuticals Other industry. This means that SPRO’s stock grew somewhat faster than GLMD’s over the last 12 months.

SPRO's P/E Growth Rating (93) in the Pharmaceuticals Major industry is in the same range as GLMD (100) in the Pharmaceuticals Other industry. This means that SPRO’s stock grew similarly to GLMD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GLMDSPRO
RSI
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
85%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
83%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
88%
MACD
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
87%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 3 days ago
76%
Declines
ODDS (%)
Bearish Trend 15 days ago
90%
Bearish Trend 9 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
85%
Aroon
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
83%
View a ticker or compare two or three
Ad is loading...
GLMDDaily Signal changed days agoGain/Loss if shorted
 
Show more...
SPRODaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DSHK0.260.01
+2.97%
Drive Shack
FECCF6.100.06
+0.99%
Frontera Energy Corp
ATEYY44.580.04
+0.09%
Advantest Corp
AIQUY41.69-0.26
-0.62%
L'Air Liquide Ord
WJRYY41.60-1.83
-4.22%
West Japan Railway Co

GLMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLMD has been closely correlated with XBIO. These tickers have moved in lockstep 88% of the time. This A.I.-generated data suggests there is a high statistical probability that if GLMD jumps, then XBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLMD
1D Price
Change %
GLMD100%
+4.88%
XBIO - GLMD
88%
Closely correlated
-5.28%
LBPH - GLMD
31%
Poorly correlated
+2.96%
JSPR - GLMD
31%
Poorly correlated
+1.87%
CDTX - GLMD
28%
Poorly correlated
+9.26%
CRVS - GLMD
28%
Poorly correlated
+0.56%
More

SPRO and

Correlation & Price change

A.I.dvisor indicates that over the last year, SPRO has been loosely correlated with IMAB. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if SPRO jumps, then IMAB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SPRO
1D Price
Change %
SPRO100%
-1.71%
IMAB - SPRO
38%
Loosely correlated
-0.53%
HRTX - SPRO
37%
Loosely correlated
+0.73%
CTMX - SPRO
37%
Loosely correlated
-0.68%
LXRX - SPRO
37%
Loosely correlated
+9.59%
NTLA - SPRO
35%
Loosely correlated
+1.67%
More